We're still hearing about patient trials of the Ebola drug Remdesivir and the malaria drug Hydroxychloroquine for treatment of Covid-19 patients, but Nobel Prize-winning professor Peter Doherty, from the Department of Microbiology and Immunology at the University of Melbourne, says neither option is shaping as a potential remedy to the pandemic. There are more than 70 potential vaccines being developed at the moment, but he doesn't think a successful option will be in place anytime soon.
Professor Peter Doherty: No Covid-19 magic bullets yet
From Sunday Morning, 8:10 am on 26 April 2020
Tags:
- health
- science
- Aids
- Australia
- China
- Covid-19
- Donald Trump
- Icu
- Italy
- Lab
- London
- MVA
- Madrid
- New Zealand
- Pacific Islands
- Remdesivir
- Scott Morrison
- air conditioner
- antibody tests
- cells
- coronavirus
- doctors
- hydroxychloroquine
- media
- nurses
- oxygen
- pandemic
- patients
- platform trial
- schools
- smallpox
- social distancing
- vaccine
- virus
- wet markets
To embed this content on your own webpage, cut and paste the following:
See terms of use.